Dana-Farber Cancer Institute: Lung Neoplasms trials

The registry lists 29 Lung Neoplasms studies with Dana-Farber Cancer Institute as lead sponsor. 7 are open to participants now and 8 have results posted.

Phase 1 5Phase 2 11No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clonal Hematopoiesis Chemotherapy and Radiation Effects StudyRecruitingNCT07675967
• Precise Exercise Regimen for Cancer Care (PERCC): A Pilot StudyRecruitingNCT07412041Not applicable
• EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx PopulationsRecruitingNCT06716580Not applicable
• Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENHANCE TrialRecruitingNCT06026111Not applicable
• Investigating Hereditary Risk In Thoracic Cancers (INHERIT)RecruitingNCT05587439
• InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerRecruitingNCT05463796
• Stereotactic Magnetic Resonance Guided Radiation TherapyRecruitingNCT04115254Not applicable
• A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid CancerTerminatedNCT03131206Phase 1/2Results posted
• Merestinib In Non-Small Cell Lung Cancer And Solid TumorsTerminatedNCT02920996Phase 2Results posted
• Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung CancerTerminatedNCT02770014Phase 2Results posted
• Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01799135Not applicableResults posted
• Dasatinib in Advanced Squamous Cell Lung CancerTerminatedNCT01491633Phase 2Results posted
• Pazopanib in Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT01253369Phase 2Results posted
• Stereotactic Boost for Locally Advanced Non-Small Cell Lung CancerTerminatedNCT01222572Phase 1/2Results posted
• Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's DiseaseCompletedNCT00601146Not applicableResults posted
• Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lung CancerCompletedNCT03170206Phase 1
• Implementation of a System-level Tobacco Treatment InterventionCompletedNCT02816697Not applicable
• A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)CompletedNCT02502695
• Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung CancerWithdrawnNCT02423148Not applicable
• PALBOCICLIB + PD-0325901 for NSCLC & Solid TumorsCompletedNCT02022982Phase 1
• INHERIT EGFR - Studying Germline EGFR MutationsActive, not recruitingNCT01754025
• Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung CancerCompletedNCT01378598Not applicable
• Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal MalignanciesCompletedNCT00973440
• Lung Cancer Symptom Assessment and Management InterventionCompletedNCT00852462Phase 2
• Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
• Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung CancerActive, not recruitingNCT00264602Phase 1
• Cetuximab and Vinorelbine in Elderly Subjects With Lung CancerCompletedNCT00165334Phase 2
• Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer PatientsCompletedNCT00137800Phase 2
• High-dose ICE With AmifostineCompletedNCT00003657Phase 2